FSPHX
Price
$25.51
Change
+$0.24 (+0.95%)
Updated
Jun 6 closing price
Net Assets
5.86B
HGHVX
Price
$41.28
Change
+$0.35 (+0.86%)
Updated
Jun 6 closing price
Net Assets
800.82M
Interact to see
Advertisement

FSPHX vs HGHVX

Header iconFSPHX vs HGHVX Comparison
Open Charts FSPHX vs HGHVXBanner chart's image
Fidelity Select Health Care
Price$25.51
Change+$0.24 (+0.95%)
VolumeN/A
Net Assets5.86B
Hartford Healthcare R6
Price$41.28
Change+$0.35 (+0.86%)
VolumeN/A
Net Assets800.82M
FSPHX vs HGHVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. HGHVX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Buy and HGHVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 5.86B vs. HGHVX (801M). HGHVX pays higher dividends than FSPHX: HGHVX (0.50) vs FSPHX (0.02). FSPHX was incepted earlier than HGHVX: FSPHX (44 years) vs HGHVX (6 years). HGHVX (0.92) is less costly to investors than FSPHX (0.63). FSPHX (40.00) and HGHVX (40.00) have comparable annual turnover. FSPHX (0) and HGHVX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -12.67 vs. HGHVX (-15.64). HGHVX return over 5 years is better than : -11.18 vs. FSPHX (-13.93).
FSPHXHGHVXFSPHX / HGHVX
Total Expense Ratio0.630.9268%
Annual Report Gross Expense Ratio0.630.9268%
Fund Existence44 years6 years-
Gain YTD-7.266-5.713127%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.86B801M732%
Annual Yield % from dividends0.020.504%
Returns for 1 year-12.67-15.6481%
Returns for 3 years-1.50-2.6257%
Returns for 5 years-13.93-11.18125%
Returns for 10 years8.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSKCX45.40N/A
N/A
Virtus KAR Mid-Cap Growth C
BEXIX17.04N/A
N/A
Baron Emerging Markets Institutional
RCEEX74.85N/A
N/A
American Funds Capital Income Bldr R2E
BRSIX11.66N/A
N/A
Bridgeway Ultra-Small Company Market
BTIRX159.87N/A
N/A
DWS Equity 500 Index R6